Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.

Bodle CR, Schamp JH, O'Brien JB, Hayes MP, Wu M, Doorn JA, Roman DL.

SLAS Discov. 2018 Apr;23(4):363-374. doi: 10.1177/2472555217752301. Epub 2018 Jan 19.

PMID:
29351497
2.

Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein-Signaling Family.

Hayes MP, Bodle CR, Roman DL.

Mol Pharmacol. 2018 Jan;93(1):25-35. doi: 10.1124/mol.117.109843. Epub 2017 Oct 19.

PMID:
29051318
3.

Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin.

Hayes MP, Soto-Velasquez M, Fowler CA, Watts VJ, Roman DL.

ACS Chem Neurosci. 2018 Feb 21;9(2):346-357. doi: 10.1021/acschemneuro.7b00349. Epub 2017 Oct 16.

PMID:
28968502
4.

Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines.

Bodle CR, Mackie DI, Hayes MP, Schamp JH, Miller MR, Henry MD, Doorn JA, Houtman JCD, James MA, Roman DL.

J Nat Prod. 2017 Jul 28;80(7):1992-2000. doi: 10.1021/acs.jnatprod.7b00112. Epub 2017 Jun 16.

5.

Effects of the herbicide triclopyr on metamorphic northern red-legged frogs.

Yahnke AE, Grue CE, Hayes MP, Pearman-Gillman S.

Environ Toxicol Chem. 2017 Sep;36(9):2316-2326. doi: 10.1002/etc.3767. Epub 2017 Mar 21.

PMID:
28186362
6.

Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells.

Bodle CR, Hayes MP, O'Brien JB, Roman DL.

Anal Biochem. 2017 Apr 1;522:10-17. doi: 10.1016/j.ab.2017.01.013. Epub 2017 Jan 20.

7.

Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting.

Antonellis PJ, Hayes MP, Adams AC.

Front Endocrinol (Lausanne). 2016 Jun 30;7:77. doi: 10.3389/fendo.2016.00077. eCollection 2016.

8.

Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.

Hayes MP, Roman DL.

AAPS J. 2016 May;18(3):550-9. doi: 10.1208/s12248-016-9894-1. Epub 2016 Feb 29. Review.

9.

Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.

Brust TF, Hayes MP, Roman DL, Burris KD, Watts VJ.

J Pharmacol Exp Ther. 2015 Mar;352(3):480-93. doi: 10.1124/jpet.114.220293. Epub 2014 Dec 24.

10.

New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.

Brust TF, Hayes MP, Roman DL, Watts VJ.

Biochem Pharmacol. 2015 Jan 1;93(1):85-91. doi: 10.1016/j.bcp.2014.10.014. Epub 2014 Nov 7.

11.

Racial disparities in the treatment of advanced epithelial ovarian cancer.

Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N.

Obstet Gynecol. 2013 Nov;122(5):1025-32. doi: 10.1097/AOG.0b013e3182a92011.

12.

Five-millimeter balloon trocar site herniation: report of two cases and review of literature.

Kanis MJ, Momeni M, Zakashansky K, Chuang L, Hayes MP.

J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):723-6. doi: 10.1016/j.jmig.2013.04.012. Epub 2013 May 25.

PMID:
23714747
13.

Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.

Conlon JM, Reinert LK, Mechkarska M, Prajeep M, Meetani MA, Coquet L, Jouenne T, Hayes MP, Padgett-Flohr G, Rollins-Smith LA.

J Chem Ecol. 2013 Jun;39(6):797-805. doi: 10.1007/s10886-013-0294-z. Epub 2013 May 8.

PMID:
23653106
14.

Effects of the herbicide imazapyr on juvenile Oregon spotted frogs.

Yahnke AE, Grue CE, Hayes MP, Troiano AT.

Environ Toxicol Chem. 2013 Jan;32(1):228-35. doi: 10.1002/etc.2048. Epub 2012 Nov 23.

PMID:
23147474
15.

Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.

Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.

Dev Comp Immunol. 2011 Jun;35(6):644-9. doi: 10.1016/j.dci.2011.01.017. Epub 2011 Feb 1.

PMID:
21295070
16.

PET/CT evaluation of cervical cancer: spectrum of disease.

Son H, Kositwattanarerk A, Hayes MP, Chuang L, Rahaman J, Heiba S, Machac J, Zakashansky K, Kostakoglu L.

Radiographics. 2010 Sep;30(5):1251-68. doi: 10.1148/rg.305105703.

PMID:
20833849
17.

Molecular alterations in uterine serous carcinoma.

Hayes MP, Ellenson LH.

Gynecol Oncol. 2010 Feb;116(2):286-9. doi: 10.1016/j.ygyno.2009.11.012. Review.

PMID:
20109727
18.

Chemotherapy for gynecologic cancers.

Rahaman J, Steiner N, Hayes MP, Chuang L, Fishman D, Gretz Iii H.

Mt Sinai J Med. 2009 Dec;76(6):577-88. doi: 10.1002/msj.20143. Review.

PMID:
20014427
19.

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma.

Hayes MP, Douglas W, Ellenson LH.

Gynecol Oncol. 2009 Jun;113(3):370-3. doi: 10.1016/j.ygyno.2008.12.021. Epub 2009 Mar 9.

20.

Augmented exercise in the treatment of deconditioning from major burn injury.

de Lateur BJ, Magyar-Russell G, Bresnick MG, Bernier FA, Ober MS, Krabak BJ, Ware L, Hayes MP, Fauerbach JA.

Arch Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S18-23.

PMID:
18036976
21.

Amino Acid derived enamides: synthesis and aminopeptidase activity.

Cesati RR 3rd, Dwyer G, Jones RC, Hayes MP, Yalamanchili P, Casebier DS.

Org Lett. 2007 Dec 20;9(26):5617-20. Epub 2007 Nov 28.

PMID:
18041848
22.

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.

Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, Ellenson LH.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5932-5.

23.

Profile of patients lost to follow-up in the Burn Injury Rehabilitation Model Systems' longitudinal database.

Holavanahalli RK, Lezotte DC, Hayes MP, Minhajuddin A, Fauerbach JA, Engrav LH, Helm PA, Kowalske KJ.

J Burn Care Res. 2006 Sep-Oct;27(5):703-12.

PMID:
16998404
24.

Statistics of the contrast of coherent images.

Fortune SA, Hayes MP, Gough PT.

J Opt Soc Am A Opt Image Sci Vis. 2004 Jul;21(7):1131-9.

PMID:
15260244
25.

Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages.

Kutza J, Crim L, Feldman S, Hayes MP, Gruber M, Beeler J, Clouse KA.

J Immunol. 2000 May 1;164(9):4955-60.

26.
27.
29.

Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development.

McRae BL, Semnani RT, Hayes MP, van Seventer GA.

J Immunol. 1998 May 1;160(9):4298-304.

30.

STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression.

Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L, Finbloom DS.

Blood. 1997 Sep 1;90(5):1768-76.

31.

Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes.

Donnelly RP, Freeman SL, Hayes MP.

J Immunol. 1995 Aug 1;155(3):1420-7.

PMID:
7636207
33.
34.

Production and action of interferons: new insights into molecular mechanisms of gene regulation and expression.

Hayes MP, Zoon KC.

Prog Drug Res. 1994;43:239-70. Review. No abstract available.

PMID:
7531856
35.

Establishment of the foreign partheonogenetic tick Amblyomma rotundatum (Acari: Ixodidae) in Florida.

Oliver JH Jr, Hayes MP, Keirans JE, Lavender DR.

J Parasitol. 1993 Oct;79(5):786-90.

PMID:
8410557
37.

Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production.

Hayes MP, Enterline JC, Gerrard TL, Zoon KC.

J Leukoc Biol. 1991 Aug;50(2):176-81.

PMID:
1649241
38.
39.

Causal association of interferon-gamma with tumor regression.

Jarpe MA, Hayes MP, Russell JK, Johnson HM, Russell SW.

J Interferon Res. 1989 Apr;9(2):239-44.

PMID:
2497201
40.

Purification and partial characterization of a receptor protein for mouse interferon gamma.

Basu M, Pace JL, Pinson DM, Hayes MP, Trotta PP, Russell SW.

Proc Natl Acad Sci U S A. 1988 Sep;85(17):6282-6.

41.

Enrichment and initial characterization of the solubilized receptor for mouse gamma interferon.

Hayes MP, Russell SW, Trotta PP, Basu M.

Biochem Biophys Res Commun. 1988 Feb 15;150(3):1096-105.

PMID:
2963631
42.

Suppressive effect of interferon-beta on development of tumoricidal activity in mouse macrophages.

Pace JL, MacKay RJ, Hayes MP.

J Leukoc Biol. 1987 Mar;41(3):257-63.

PMID:
3104517
43.

Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach.

Russell JK, Hayes MP, Carter JM, Torres BA, Dunn BM, Russell SW, Johnson HM.

J Immunol. 1986 May 1;136(9):3324-8.

PMID:
2420886

Supplemental Content

Loading ...
Support Center